These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 4073846

  • 1. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA, Emerson RG, Warner CL, Rowland LP, Salen G.
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Tint GS.
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
    Kondo R, Wakamatsu N, Ishikawa A, Yuasa T, Miyatake T.
    Rinsho Shinkeigaku; 1991 Jun; 31(6):677-9. PubMed ID: 1934787
    [Abstract] [Full Text] [Related]

  • 11. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
    Tint GS, Ginsberg H, Salen G, Le NA, Shefer S.
    J Lipid Res; 1989 May; 30(5):633-40. PubMed ID: 2760539
    [Abstract] [Full Text] [Related]

  • 12. Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid.
    Mondelli M, Rossi A, Scarpini C, Dotti MT, Federico A.
    Arch Neurol; 1992 May; 49(5):469-75. PubMed ID: 1316120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
    Björkhem I, Skrede S, Buchmann MS, East C, Grundy S.
    Hepatology; 1987 May; 7(2):266-71. PubMed ID: 3557306
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM, Salen G, Shefer S.
    N Engl J Med; 1984 Dec 27; 311(26):1649-52. PubMed ID: 6504105
    [Abstract] [Full Text] [Related]

  • 17. Cerebrotendinous xanthomatosis is treatable.
    White SW.
    Pediatr Dermatol; 1985 Jul 27; 2(4):294-6. PubMed ID: 3925446
    [Abstract] [Full Text] [Related]

  • 18. [Two cases of familial cerebrotendinous xanthomatosis--intrahepatic enzyme assay and therapeutic trial with chenodeoxycholic acid].
    Orimo S, Kobayashi T, Furukawa T, Tsukagoshi H, Kano I.
    Rinsho Shinkeigaku; 1984 Jan 27; 24(1):38-44. PubMed ID: 6467736
    [No Abstract] [Full Text] [Related]

  • 19. [Cerebrotendinous xanthomatosis--a case of brain MRI abnormality and osteoporosis].
    Kubota R, Nakagawa M, Nakamura A, Kuriyama M, Osame M.
    Rinsho Shinkeigaku; 1992 May 27; 32(5):488-93. PubMed ID: 1333927
    [Abstract] [Full Text] [Related]

  • 20. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
    Berginer VM, Foster NL, Sadowsky M, Townsend JA, Siegel GJ, Salen G.
    Am J Psychiatry; 1988 Mar 27; 145(3):354-7. PubMed ID: 3344851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.